2B78.DE vs. 8TI.DE
2B78.DE (iShares Healthcare Innovation UCITS ETF) is Health & Biotech Equities fund tracking the iSTOXX® FactSet Breakthrough Healthcare, while 8TI.DE (Stellantis NV) is a stock. Over the past 5 years, 2B78.DE returned -1.46%/yr vs -16.21%/yr for 8TI.DE. At a 0.34 correlation, their price movements are largely independent.
Performance
2B78.DE vs. 8TI.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B78.DE achieves a 6.74% return, which is significantly higher than 8TI.DE's -45.71% return.
2B78.DE
- 1D
- 1.35%
- 1M
- 8.85%
- YTD
- 6.74%
- 6M
- 6.60%
- 1Y
- 27.75%
- 3Y*
- 6.56%
- 5Y*
- -1.46%
- 10Y*
- —
8TI.DE
- 1D
- -0.97%
- 1M
- -24.11%
- YTD
- -45.71%
- 6M
- -45.31%
- 1Y
- -39.72%
- 3Y*
- -26.76%
- 5Y*
- -16.21%
- 10Y*
- 7.30%
2B78.DE vs. 8TI.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
2B78.DE iShares Healthcare Innovation UCITS ETF | 6.74% | 5.61% | 7.18% | -0.29% | -19.05% | 1.20% | 38.70% | 16.67% | 0.39% | 19.53% |
8TI.DE Stellantis NV | -45.71% | -18.85% | -36.17% | 73.75% | -13.81% | 41.45% | 10.94% | 22.91% | -15.90% | 74.15% |
Correlation
The correlation between 2B78.DE and 8TI.DE is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2016 | 0.34 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B78.DE vs. 8TI.DE — Risk / Return Rank
2B78.DE
8TI.DE
2B78.DE vs. 8TI.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF (2B78.DE) and Stellantis NV (8TI.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| 2B78.DE | 8TI.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.47 | ||
| Sortino ratioReturn per unit of downside risk | +3.40 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 0.88 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 2.30 | -0.78 | +3.08 |
| Martin ratioReturn relative to average drawdown | 5.65 | -1.53 | +7.18 |
Loading charts...
Drawdowns
2B78.DE vs. 8TI.DE - Drawdown Comparison
The maximum 2B78.DE drawdown since its inception was -38.59%, smaller than the maximum 8TI.DE drawdown of -83.71%. Use the drawdown chart below to compare losses from any high point for 2B78.DE and 8TI.DE.
Loading charts...
Drawdown Indicators
| 2B78.DE | 8TI.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.59% | -83.71% | +45.12% |
Max Drawdown (1Y)Largest decline over 1 year | -12.00% | -50.86% | +38.86% |
Max Drawdown (3Y)Largest decline over 3 years | -25.32% | -78.00% | +52.68% |
Max Drawdown (5Y)Largest decline over 5 years | -37.03% | -78.00% | +40.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -78.00% | — |
Current DrawdownCurrent decline from peak | -11.68% | -78.00% | +66.32% |
Average DrawdownAverage peak-to-trough decline | -15.27% | -29.94% | +14.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.90% | 25.86% | -20.96% |
Volatility
2B78.DE vs. 8TI.DE - Volatility Comparison
The current volatility for iShares Healthcare Innovation UCITS ETF (2B78.DE) is 5.25%, while Stellantis NV (8TI.DE) has a volatility of 10.77%. This indicates that 2B78.DE experiences smaller price fluctuations and is considered to be less risky than 8TI.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B78.DE | 8TI.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.25% | 10.77% | -5.52% |
Volatility (6M)Calculated over the trailing 6-month period | 12.04% | 41.64% | -29.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.31% | 50.94% | -34.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.97% | 38.58% | -20.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.93% | 39.68% | -19.75% |
Dividends
2B78.DE vs. 8TI.DE - Dividend Comparison
Neither 2B78.DE nor 8TI.DE has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
2B78.DE iShares Healthcare Innovation UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
8TI.DE Stellantis NV | 0.00% | 7.20% | 12.21% | 6.31% | 7.80% | 13.50% | 0.00% | 15.45% | 0.00% | 0.00% | 0.12% |
Frequently Asked Questions
2B78.DE and 8TI.DE have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for 2B78.DE and 8TI.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer